2024 CTR Exam-Data Collection Abstracting, Coding

2024 CTR Exam-Data Collection (Abstracting, Coding) Complete Answers 100% Correct (Latest 2024) Exam

• The process of converting the medical record information into standardized codes within a uniform

data set is

Answer: Abstracting

• Pediatric tumors are analyzed by rather than origination site.

Answer: type

• Benign and borderline CNS and brain tumors became reportable effective

Answer: January 1, 2004 per Benign Tumor Cancer Registries Amendment Act

• All benign/borderline Central Nervous System (CNS) and Intracranial (brain et al) tumors with a

behvior code of /0 and /1 and all cases with a behavior code of /2 and /3 in ICDO-3, except: squamous and basal cell carcinomas of skin (after 01/01/2003)(except repro- ductive), Carcinoma In Situ of cervix and Intraepthelial neoplasm of cervix (CIN) III , prostate (PIN) III, vulva (VIN) III, vagina (VAIN) III, and anus (AIN)III. (after 01/01/1996)

Answer: Reportable Diagnosis

• Analytic cases

Answer: Patients who were diagnosed or who received any part of first course of treatment at the hospital

• Non-analytic cases

Answer: Patients who receive non-first course treatment for a cancer, patients pursing second opinion, patients with a hx of cancer but being seen for another condition

7. Examples of sources:

pathology reports disease index medical record reports radiation oncology logs medical oncology logs outpatient records radiology reports other hospitals, nursing homes, out of state facilities, hospitces, outpatient centers, physician offices, death clearance

Answer: Casefinding

• Date of first contact

Answer: Date the patient was first physically seen at the facility for a cancer diagnosis or treatment

• Non-Reportable diagnoses

Answer: squamous and basal cell carcinomas of skin (after 01/01/2003)(except reproductive), CIS of cervix and CIN III ,PIN III, VIN III, AINIII(after 01/01/1996)

• / 4

• Systematic method for identifying all eligible cases to be included in the cancer registry database

Answer: Casefinding

• Death certificate only benchmark rates by CCR agencies

Answer: Seer no more than 1.5%

NAACCR 3-5%

• Casefinding timliness benchmark rates for NAACCR, SEER, NPCR

Answer:

NAAC- CR at least 95% be avail w/in 23 months of dx SEER complete counts w/in 22 months of dx NPCR 90% be avail within 12 mos; 95% within 24 mos CoC 90% be abstracted within 6 months of date of first contact

• Ambiguous terms that constitute a diagnosis

Answer: apparently appears

comparable with compatible with consistent with favors malginant appearing most likely neoplasm * only for brain, CNS presumed probable suspected suspicous for tumor* only for brain, CNS typical of

• T or F? Abstract cytology with ambigous term only if positive biopsy or physician clinical

impression of cancer support cytology findings

Answer: True

• Ambigous terms that DO NOT constitue a dx of CA without add'l information

Answer:

Cannot be rules out equivocal possible potentially malignant questionable rule out suggests worrisome bordering on concerning for

• Requests from the facility's cancer committee or central registry to collect information about tumors

that are not required to be abstracted by the CoC for accredited programs are called cases.

Answer: Reportable by Agreement

• Class of case -- to --are analytic cases

Answer: 00-22

• Class of case -- to -- are included in treatment and survival analysis

Answer: 10-22

• / 4

• Analytic class of case -- dx on or after January 1, 2006 are not required to be staged or followed

Answer: 00

• class of case --to-- are non-analytic

Answer: 30-99

• The CoC does not require registries to accession, abstract, or follow class of case -- to -- but the

program or central registry may require them

Answer: 30-99

• The date the registry database started which is always January 1

Answer: reference date

• What is the CoC's retention timeframe

Answer: abstracts may be destroyed one year after the patient expires

• The accession number is a 9 digit number first 4 digists represent

Answer: the year patient was first seen at the facility

• The accession number is a 9 digit number last 5 digits represent

Answer: The sequential order in which the patient was entered into the database for that year

• The sequence 00 means the patient has malignant primary cancer

Answer: -one

• The sequence numbers are divided into 2 groups and

Answer:

• malignant and in situ
• Non-malignant

• GISTS with mets, positive LNs or must have behavior changed to /3 and be

abstracted

Answer: multiple foci

• Brushings, washings, cells aspirates are not procedures

Answer: surgical diagnostic staging procedures

• Excisional biopsies of primary site are coded as procedures

Answer: surgical procedure of primary site

• Do not code procedures that excise, aspirate or remove lymph nodes to diagnose or stage cancer in

"surgical diagnostic staging procedures". Code as Answer: code in scope of regional lymph node surgery under surgical procedure of primary site 3 / 4

• staging rules: Information obtained before treatment or within 4 months of date of diagnosis

(whichever is shorter)

Answer: Clinical staging

• staging rules: Information through the first course surgery or within 4 months of date of

diagnosis (whichever is longer)

Answer: Pathological staging

• reporting is considered when cases are need for epidemiologic protocls, research or tumor

board presentation at hospitals. Using this method cases are identified within days.

Answer: Rapid case reporting

15-30 days after diagnosis or admission

• Local recurrence

Answer: recurrence in primary organ

• trocar recurrence

Answer: recurrence in scar tissue of removed organ

• regional recurrence

Answer: recurrence in adjacent organ or lymph nodes

• distance recurrence

Answer: recurrence in location beyond regional

• suspense system

Answer: system cancer registry uses to maintain identified cases on casefinding but not yet abstracted.

• What is the follow-up percentage maintenance rate for all analytic patients from the cancer registry's

reference date?

Answer: 80%

• What is the follow-up percentage maintainance rate for all analytic patients within the last 5 years?

Answer: 90%

• The group of data items required to be collected by a standard setting organization

Answer: data set

• What are the 3 major objectives of a cancer registry?

Answer:

• Identify and accession all cases meeting criteria for inclusion in the registry
• Develop and implement a quality control program
• / 4